Viewing Study NCT01740557


Ignite Creation Date: 2025-12-24 @ 7:00 PM
Ignite Modification Date: 2026-02-08 @ 4:05 AM
Study NCT ID: NCT01740557
Status: COMPLETED
Last Update Posted: 2024-10-08
First Post: 2012-11-30
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Genetically Modified Therapeutic Autologous Lymphocytes Followed by Aldesleukin in Treating Patients With Stage III or Metastatic Melanoma
Sponsor: M.D. Anderson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Melanoma View
None Stage III Cutaneous Melanoma AJCC v7 View
None Stage IV Cutaneous Melanoma AJCC v6 and v7 View
Keywords: